Scholarlink

Abstract <p>Licochalcone A (LCA), a natural flavonoid with potent anti-inflammatory properties, has shown promise as a neuroprotective agent. However, its ability to cross the blood–brain barrier (BBB) and exert central effects remains underexplored. In this study, we demonstrate for the first time that LCA enhances cognitive function in a lipopolysaccharide (LPS)-induced neuroinflammatory mouse model and effectively penetrates the BBB. Following intraperitoneal administration of LCA (20&#xa0;mg/kg), behavioral assessments via novel object recognition and Y-maze tests revealed significant improvements in non-spatial and spatial short-term memory. To investigate whether LCA is able to cross the BBB, we first developed and validated a sensitive GC–MS/MS method (LOD, 0.14&#xa0;µg/mL; LOQ, 0.42&#xa0;µg/mL) capable of quantifying LCA in brain tissue. The method revealed LCA brain concentrations peaking at 4&#xa0;h (<i>T</i><sub>max</sub>), with sustained levels above 15&#xa0;µg/mg up to 8&#xa0;h post-injection. Notably, LPS-pretreated animals exhibited higher BBB permeability to LCA, suggesting inflammation-enhanced CNS penetration. This is the first report to confirm LCA’s brain permeability and provide pharmacokinetics in brain tissue. Our findings not only validate the central neuroprotective potential of LCA but also establish a reliable analytical method for the detection of LCA.</p> Graphical Abstract <p>Licochalcone A (LCA) enhanced the cognition in the LPS-neuroinflammatory mouse model. To further understand its neuroprotective effect, a rapid sensitive GC–MS/MS bioanalytical method has been established to confirm LCA’s passage through the blood–brain barrier and perform a pharmacokinetics profiling in mice’s brain samples.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Detection and pharmacokinetics of licochalcone A in brains of neuroinflammatory mouse model

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月8日

查看全文
  • Dalia Nour,
  • Azza El-Azzhary,
  • Rasha Hanafi,
  • Reham M. Abdelkader

摘要

Abstract

Licochalcone A (LCA), a natural flavonoid with potent anti-inflammatory properties, has shown promise as a neuroprotective agent. However, its ability to cross the blood–brain barrier (BBB) and exert central effects remains underexplored. In this study, we demonstrate for the first time that LCA enhances cognitive function in a lipopolysaccharide (LPS)-induced neuroinflammatory mouse model and effectively penetrates the BBB. Following intraperitoneal administration of LCA (20 mg/kg), behavioral assessments via novel object recognition and Y-maze tests revealed significant improvements in non-spatial and spatial short-term memory. To investigate whether LCA is able to cross the BBB, we first developed and validated a sensitive GC–MS/MS method (LOD, 0.14 µg/mL; LOQ, 0.42 µg/mL) capable of quantifying LCA in brain tissue. The method revealed LCA brain concentrations peaking at 4 h (Tmax), with sustained levels above 15 µg/mg up to 8 h post-injection. Notably, LPS-pretreated animals exhibited higher BBB permeability to LCA, suggesting inflammation-enhanced CNS penetration. This is the first report to confirm LCA’s brain permeability and provide pharmacokinetics in brain tissue. Our findings not only validate the central neuroprotective potential of LCA but also establish a reliable analytical method for the detection of LCA.

Graphical Abstract

Licochalcone A (LCA) enhanced the cognition in the LPS-neuroinflammatory mouse model. To further understand its neuroprotective effect, a rapid sensitive GC–MS/MS bioanalytical method has been established to confirm LCA’s passage through the blood–brain barrier and perform a pharmacokinetics profiling in mice’s brain samples.